Immunopeptidomic MHC-I profiling and immunogenicity testing identifies Tcj2 as a new Chagas disease mRNA vaccine candidate.

Saved in:
Bibliographic Details
Title: Immunopeptidomic MHC-I profiling and immunogenicity testing identifies Tcj2 as a new Chagas disease mRNA vaccine candidate.
Authors: Versteeg, Leroy1,2 (AUTHOR) Leroy.Versteeg@bcm.edu, Adhikari, Rakesh1 (AUTHOR), Robinson, Gonteria1 (AUTHOR), Lee, Jungsoon1 (AUTHOR), Wei, Junfei1 (AUTHOR), Islam, Nelufa1 (AUTHOR), Keegan, Brian1 (AUTHOR), Russell, William K.3 (AUTHOR), Poveda, Cristina1 (AUTHOR), Villar, Maria Jose1 (AUTHOR), Jones, Kathryn1,4 (AUTHOR), Bottazzi, Maria Elena1,4,5 (AUTHOR), Hotez, Peter1,4,5 (AUTHOR), Tijhaar, Edwin2 (AUTHOR) Edwin.Tijhaar@wur.nl, Pollet, Jeroen1 (AUTHOR) Jeroen.Pollet@bcm.edu
Source: PLoS Pathogens. 12/18/2024, Vol. 20 Issue 12, p1-35. 35p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:15537366
DOI:10.1371/journal.ppat.1012764